Open-label Prospective Clinical Trial Evaluating the Safety and Efficacy of Biosynthetic CLP-PEG-MPC Corneal Implants in Patients Undergoing High-risk Deep Anterior Lamellar Keratoplasty.
Stopped further biomaterial optimization
Conditions
- High-risk Corneal Transplantation
- Corneal Blindess
- Corneal Inflammation
- Deep Anterior Lamellar Keratoplasty
Interventions
- DEVICE: CLP-PEG-MPC
- PROCEDURE: Human donor cornea penetrating keratoplasty
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators